Botanix Pharmaceuticals Limited
BXPHF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $65 | $79 | $10 | $7 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3 | $1 | $0 | $0 |
| Inventory | $28 | $1 | $3 | $3 |
| Other Curr. Assets | $3 | $2 | $0 | $0 |
| Total Curr. Assets | $100 | $83 | $14 | $11 |
| Property Plant & Equip (Net) | $1 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $28 | $29 | $11 | $3 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | -$0 | -$0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $30 | $30 | $11 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $129 | $112 | $25 | $14 |
| Liabilities | – | – | – | – |
| Payables | $9 | $3 | $1 | $5 |
| Short-Term Debt | $9 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $1 | $0 | $1 |
| Total Curr. Liab. | $25 | $4 | $2 | $6 |
| LT Debt | $23 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $23 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $0 | $0 | $0 |
| Total Liabilities | $48 | $4 | $2 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $226 | $188 | $93 | $71 |
| Retained Earnings | -$177 | -$91 | -$77 | -$68 |
| AOCI | $32 | $11 | $6 | $4 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $81 | $109 | $23 | $8 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $129 | $112 | $25 | $14 |
| Net Debt | -$33 | -$79 | -$10 | -$7 |